Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Kilroy Realty
KRC
$4.22B
| $3.42M | 0.01% |
55,300
+48,786
| +749% | +$2.74M |
|
1902
Saic
SAIC
$5.36B
| $3.42M | 0.01% |
+64,100
| New | +$2.85M |
|
1903
Thomson Reuters
TRI
$44.9B
| $3.41M | 0.01% |
72,469
-72,555
| -50% | -$3.12M |
|
1904
ON Semiconductor
ON
$32.2B
| $3.41M | 0.01% |
355,296
-599,600
| -63% | -$5.14M |
|
1905
United-Guardian
UG
$32.8M
| $3.4M | 0.01% |
164,600
+7,900
| +5% | +$168K |
|
|
GBNK
1906
DELISTED
Guaranty Bancorp
GBNK
| $3.39M | 0.01% |
219,320
-13,200
| -6% | -$203K |
|
1907
Citizens & Northern Corp
CZNC
$466M
| $3.38M | 0.01% |
169,860
+42,860
| +34% | +$859K |
|
|
ANCX
1908
DELISTED
Access National Corp
ANCX
| $3.37M | 0.01% |
169,700
-24,000
| -12% | -$447K |
|
1909
Avient
AVNT
$4.25B
| $3.35M | 0.01% |
+110,858
| New | +$3.05M |
|
|
TCP
1910
DELISTED
TC Pipelines LP
TCP
| $3.35M | 0.01% |
69,500
+24,600
| +55% | +$1.11M |
|
|
KNL
1911
DELISTED
Knoll, Inc.
KNL
| $3.34M | 0.01% |
154,100
-59,700
| -28% | -$1.12M |
|
1912
Pitney Bowes
PBI
$2.25B
| $3.33M | 0.01% |
+154,700
| New | +$2.94M |
|
|
UMPQ
1913
DELISTED
Umpqua Holdings Corp
UMPQ
| $3.33M | 0.01% |
210,000
+192,900
| +1,128% | +$2.91M |
|
1914
Amphenol
APH
$206B
| $3.33M | 0.01% |
230,400
-1,540,000
| -87% | -$20M |
|
|
KE
1915
Kimball Electronics
KE
$622M
| $3.32M | 0.01% |
297,275
+3,800
| +1% | +$40.7K |
|
|
CKH
1916
DELISTED
Seacor Holdings Inc.
CKH
| $3.32M | 0.01% |
+63,074
| New | +$2.91M |
|
1917
Fluor
FLR
$7B
| $3.32M | 0.01% |
61,800
+24,800
| +67% | +$1.17M |
|
1918
ESCO Technologies
ESE
$7.92B
| $3.31M | 0.01% |
84,800
-15,803
| -16% | -$559K |
|
1919
Old National Bancorp
ONB
$10.4B
| $3.3M | 0.01% |
+270,685
| New | +$3.19M |
|
1920
Citi Trends
CTRN
$616M
| $3.29M | 0.01% |
184,500
-36,200
| -16% | -$677K |
|
|
FNFV
1921
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $3.28M | 0.01% |
302,400
+101,400
| +50% | +$1.01M |
|
|
CMRX
1922
DELISTED
Chimerix, Inc.
CMRX
| $3.27M | 0.01% |
+640,388
| New | +$4.18M |
|
|
KTWO
1923
DELISTED
K2M Group Holdings, Inc
KTWO
| $3.27M | 0.01% |
220,300
+160,400
| +268% | +$2.2M |
|
1924
Nature's Sunshine
NATR
$266M
| $3.27M | 0.01% |
340,100
+53,000
| +18% | +$458K |
|
|
GGP
1925
DELISTED
GGP Inc.
GGP
| $3.26M | 0.01% |
109,800
-18,600
| -14% | -$511K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.